Insider · CIK 0001023225
Jack L Wyszomierski
director
Files at EXEL (EXELIXIS, INC.). First filing Feb 28, 2025, latest Jun 4, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $656k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EXEL: EXELIXIS, INC.
EXELOct 9, 2026 · close 59.86
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 24Weak | EXELIXIS, INC. | $325k 7,535 shares | -2% | +68% from low-8% from high | |
| 10Weak | EXELIXIS, INC. | $331k 8,768 shares | -2% | +52% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | EXEL EXELIXIS, INC. | SOpen-market sale Common Stock10b5-1 | -7,535 | $43.09 | $325k | 358,882 | Jun 4, 2025 |
| May 29, 2025 | EXEL EXELIXIS, INC. | AGrant or award Common Stock | +9,812 | $0.00 | $0 | 366,417 | May 30, 2025 |
| Feb 28, 2025 | EXEL EXELIXIS, INC. | MOption exercise Common Stock10b5-1 | +15,874 | $20.50 | $325k | 365,373 | Feb 28, 2025 |
| Feb 28, 2025 | EXEL EXELIXIS, INC. | SOpen-market sale Common Stock10b5-1 | -8,768 | $37.80 | $331k | 356,605 | Feb 28, 2025 |
| Feb 28, 2025 | EXEL EXELIXIS, INC. | MOption exercise Option (right to buy)derivative10b5-1 | -15,874 | $0.00 | $0 | 0 | Feb 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.